Filing Details
- Accession Number:
- 0000059478-22-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 16:38:11
- Reporting Period:
- 2022-02-25
- Accepted Time:
- 2022-02-28 16:38:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
59478 | Eli Lilly & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1561539 | A Donald Zakrowski | Lilly Corporate Center Indianapolis IN 46285 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-02-25 | 1,660 | $243.84 | 7,274 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,684 | Indirect | 401(k) |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.